Rapid detection of the fibrinogen Aα16Arg→His mutation

Clinical Chemistry

Volumn 43, Issue 11, 1997, Pages 2184-2186

  Ridgway, Hayley J ^a   Brennan, Stephen O ^a   Fellowes, Andrew P ^a   George, Peter M ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; SERUM ALBUMIN; THROMBIN;

AMINO ACID SEQUENCE; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; DNA SEQUENCE; DYSFIBRINOGENEMIA; FAMILIAL DISEASE; GENE MUTATION; GENE STRUCTURE; HUMAN; PRACTICE GUIDELINE; SEQUENTIAL ANALYSIS;

EID: 0030710494     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.11.2184     Document Type: Article

References (10)

1. Bithell TC. Hereditary dysfibrinogenemia. Clin Chem 1988;31:509-16.
2. Henschen AH. Human fibrinogen - structural variants and functional sites. Thromb Haemost 1993;70:42-7.
3. Matsuda M, Yoshidi N, Terukina S, Kensuke Y, Maekawa H. Molecular abnormalities of fibrinogen - the present status of structure elucidation. In: Matsuda M, Iwanaga S, Takada A, Henschen A, eds. Fibrinogen 4: current basic and clinical aspects. Amsterdam: Elsevier Science Publishers, 1990: 139-51.
4. Brennan SO, Hammonds B, George PM. Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (Aα20Val→Asp). J Clin Invest 1995;96:2854-8.
5. Ciulla TA, Sklar RM, Hauser SL. A simple method for DNA purification from peripheral blood. Anal Biochem 1988;174:485-8.
6. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487-91.
7. Gorkun OV, Veklich YI, Medved LV, Henschen AH, Weisel JW. Role of the αC domains of fibrin in clot formation. Biochemistry 1994;33:6986-97.
8. Bögli C, Cofrancesco E, Cortellaro M, Della Volpe A, Hofer A, Furlan M, Zanussi C. Fibrinogen Milano VI: a heterozygous dysfibrinogenaemia (Aα16 Arg→His) with bleeding tendency. Eur J Haematol 1990;45:26-30.
9. Siebenlist KR, Prchal JT, Mosesson MW. Fibrinogen Birmingham: a heterozygous dysfibrinogenemia (Aα16Arg→His) containing heterodimeric molecules. Blood 1988;71:613-8.
10. Alving BM, Henschen AH. Fibrinogen Giessen I: a congenital homozygously expressed dysfibrinogenemia with Aα16Arg→His substitution. Am J Hematol 1987;25:479-82.